The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

techMARK: A focus on innovation


techMARK and techMARK mediscience are specialist segments of the Main Market focusing on innovative technology and healthcare companies.           

The Main Market is the only market to provide a focus of this type, reflecting the Exchange’s recognition of technological innovation as a driver of global economic and social development.

Benefits of techMARK

  • Clear identification as an innovative company operating in technology and/or healthcare
  • Membership of a community committed to investing in research and development
  • Increased investor and media awareness through inclusion in the FTSE techMARK Index Series and associated funds

techMARK is supported by an independent panel of industry experts – the techMARK Admissions Panel. With representation from trade bodies, the corporate finance, fund management, legal and accounting professions, the Panel advises on the eligibility of specific companies for techMARK and techMARK mediscience and reviews as appropriate the overall approach to eligibility.

For more information on joining techMARK and techMARK mediscience please contact the Exchange’s Business Development team on 020 7797 3429 or email equityprimarymarkets@londonstockexchange.com.

techMARK Factsheet (pdffile pdf - 348 KB)

techMARK Eligibility Guidance (pdffile pdf - 395 KB)

.

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds